Gut Microbiota Dysbiosis in Childhood Vasculitis: A Perspective Comparative Pilot Study

Marianna Fabi1, Federica D'Amico2, Silvia Turroni3

  • 1Pediatric Emergency Unit, Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.

Insights

Gut microbiota alterations are linked to childhood vasculitis like Kawasaki disease (KD) and Henoch-Schönlein purpura (HSP). Beneficial gut bacteria were reduced in KD and HSP patients, suggesting new therapeutic targets.

Area of Science:

  • Pediatric Rheumatology
  • Microbiology
  • Immunology

Background:

  • Kawasaki disease (KD) and Henoch-Schönlein purpura (HSP) are common childhood vasculitides.
  • A multifactorial etiology involving genetic predisposition and immune dysregulation is suspected.
  • Gut microbiota (GM) alterations may trigger or exacerbate the hyperimmune response in these conditions.

Purpose of the Study:

  • To investigate the gut microbiota composition in children with KD.
  • To compare the GM profiles of KD patients with those of HSP patients and febrile controls.
  • To identify potential GM signatures associated with KD and HSP.

Main Methods:

  • 16S rRNA gene sequencing was employed to profile the gut microbiota.
  • Children diagnosed with KD, HSP, and febrile illness (F) were enrolled.
  • GM profiles were compared against healthy control cohorts from previous studies.

Main Results:

  • Gut microbiota composition significantly differed between KD, HSP, and febrile children compared to controls.
  • A reduction in the relative abundance of beneficial Ruminococcaceae and Lachnospiraceae families was observed in patients.
  • Distinct GM signatures were identified, including lower levels of Dialister in KD and Clostridium/Akkermansia in HSP. Dysbiosis was more pronounced in patients with abdominal involvement.

Conclusions:

  • This study provides the first analysis of GM in a predominantly Caucasian cohort of KD and HSP children.
  • Alterations in gut microbiota composition are associated with childhood vasculitis.
  • Findings suggest potential GM-targeted therapeutic strategies for KD and HSP.